Novel Biomarkers for Early Diagnosis and Progression of Alzheimer’s Disease: A Comprehensive Review

Article Sidebar

PDF
Published: Jun 25, 2026
DOI: https://doi.org/10.22377/ijpba.v17i02.2275

Main Article Content

Anup Kumar Chakraborty
Department of Pharmacy Chemistry, B.R. Nahata College of Pharmacy, Faculty of Pharmacy, Mandsaur University, Mandsaur, Madhya Pradesh, India

Abstract

lzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory impairment, posing a significant global healthcare burden. Early diagnosis remains challenging due to reliance on late-stage clinical symptoms, by which time irreversible neuronal damage has already occurred.

Downloads

Download data is not yet available.

Article Details

How to Cite
Chakraborty, A. K. (2026). Novel Biomarkers for Early Diagnosis and Progression of Alzheimer’s Disease: A Comprehensive Review. International Journal of Pharmaceutical & Biological Archive, 17(02). https://doi.org/10.22377/ijpba.v17i02.2275
Issue
Vol. 17 No. 02 (2026): International Journal of Pharmaceutical and Biological Archive
Section
Review Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.